STAT revealed plans to convene an in-person gathering on the morning of Wednesday, Nov. 18, during the HLTH conference in Las Vegas. This update was circulated to readers through the web edition of STAT’s Health Tech newsletter. In addition to the event details, the edition addresses an investigation concerning EPIC alongside recent developments regarding Teladoc. Full access to the underlying newsletters and reporting is limited to paying STAT+ subscribers.
Key points
STAT is expanding its physical presence at major industry gatherings through scheduled pr…: STAT is expanding its physical presence at major industry gatherings through scheduled programming at the HLTH conference.
Comprehensive analysis regarding digital health leaders like EPIC and Teladoc is reserved…: Comprehensive analysis regarding digital health leaders like EPIC and Teladoc is reserved exclusively for paying subscribers.
The outlet utilizes its specialized Health Tech newsletter to deliver both event notices…: The outlet utilizes its specialized Health Tech newsletter to deliver both event notices and critical industry reporting.
Sources checked by our analysis pipeline: 1
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Big news: STAT is taking over a stage at HLTH in Las Vegas on the morning of Wednesday, Nov. 18.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Critical digital booking platforms and consultation tools have gone dark across multiple regions, directly threatening mandatory access targets for primary care. The sudden vendor failure forces affected surgeries to revert to manual scheduling methods, adding immediate administrative strain to already stretched clinic staff. Medical leaders are urgently calling on health authorities to intervene and stabilize digital operations.
Federal regulators are targeting opaque pharmaceutical practices by forcing pharmacy benefit managers to unveil their hidden compensation arrangements directly to corporate clients. The measure aims to curb health care spending by giving companies a clear view of rebates, consulting fees, and pricing markups. Officials anticipate this unprecedented transparency will lower overall medication costs across the commercial insurance market.